Impact ledger
Aptevo Therapeutics Inc. (APVO): the developments shaping its investment case
Follow the evidence affecting Aptevo Therapeutics Inc.'s valuation assumptions. Review the key developments below. Continue in Market Ontology to test your assumptions, examine related opportunities, and save the investment case you want to track.
Test assumptions, examine opportunities, and save your research.
Material developments
Evidence affecting valuation assumptions
Each entry names the assumption the evidence touches and how the evidence reads. Direction describes the business mechanism, not a stock-price conclusion.
| Date | Assumption | Direction | Interpretation |
|---|---|---|---|
| 2026-08-14 | multiple | Bearish | Incremental float typically compresses near-term multiple absent revenue acceleration. |
| 2026-08-14 | share_count | Bullish | Primary equity issuance increases diluted share count. |
Event impact log
3 events mapped to APVO since 2026-08-14. Evidence through 2026-09-03.
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-09-03 | Aptevo Therapeutics Reports 93% Clinical Benefit Rate with Mipletamig Triplet in AML | Direct positive clinical trial results for lead candidate, increasing probability of regulatory approval and future commercialization. | Bullish | 1-3m | 0.90 |
| 2026-08-14 | Niowave Makes Strategic Equity Investment in Aptevo Therapeutics Inc. | Direct equity investment provides capital; strategic collaboration offers potential for new revenue streams and pipeline development. | Bullish | 1-3m | 0.70 |
| 2026-08-14 | Niowave Makes Strategic Equity Investment in Aptevo Therapeutics Inc. | Dilution from equity issuance; long-term success of collaboration is uncertain. | mixed | 1-5y | 0.40 |
Continue this research
Build your Aptevo Therapeutics Inc. investment case. Continue from the evidence above, change the assumptions the developments move, and save the work to revisit as the case develops.
This ledger is regenerated from Market Ontology's public event pipeline. View the APVO entity page →